Anti-TNFα Therapy for Inflammatory Bowel Diseases is Associated With Epstein-Barr Virus Lytic Activation

Anti-TNFα therapy, known to suppress T-cell immunity, is increasingly gaining popularity for treatment of autoimmune diseases including inflammatory bowel diseases (IBD). T-cell suppression increases the risk of B-cell EBV-lymphoproliferative diseases and lymphomas. Since EBV-lytic activation is ess...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Med Virol
Hlavní autoři: Lapsia, Sameer, Koganti, Siva, Spadaro, Salvatore, Rajapakse, Ramona, Chawla, Anupama, Bhaduri-McIntosh, Sumita
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5868340/
https://ncbi.nlm.nih.gov/pubmed/26307954
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.24331
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky